feed,title,long_url,short_url
SeekingAlpha,Sensata Technologies: Weak Win Rate Should Continue To Pressure Near-Term Valuation,https://seekingalpha.com/article/4622742,
SeekingAlpha,Keros Therapeutics: Hematological Therapies Continue To Advance,https://seekingalpha.com/article/4622739,
